196 related articles for article (PubMed ID: 6820904)
1. [Concentration of 5-FU level in the tissue and blood of the patients with breast cancer by preoperative administration of UFT].
Suemasu K; Nomoto C; Higashi Y
Gan To Kagaku Ryoho; 1982 Apr; 9(4):667-71. PubMed ID: 6820904
[TBL] [Abstract][Full Text] [Related]
2. [Level of 5-FU in tumor tissues of the patients with head and neck malignant tumors after oral administration of UFT].
Kusama M; Utsunomiya Y; Ono T; Nagura H; Enomoto S
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1796-802. PubMed ID: 6411004
[TBL] [Abstract][Full Text] [Related]
3. [5-FU concentration in the tissues (tumor and lymph node) of breast cancer patients given preoperative administration of UFT and FT].
Koida T; Kimura M
Gan To Kagaku Ryoho; 1985 May; 12(5):1147-51. PubMed ID: 3922313
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetics and a phase I study of tegafur-uracil enterogranules in cancer patients].
Kamiya O; Hoshino A; Ohara K; Nagata K; Kojima T; Sugihara T; Yamada M; Suzuki M; Kimura K; Fujii S
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2565-72. PubMed ID: 6418079
[TBL] [Abstract][Full Text] [Related]
5. [5-FU concentration in blood and tissue of patients with primary lung cancer after oral administration of UFT].
Oiwa T; Saito H
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):525-30. PubMed ID: 3082289
[TBL] [Abstract][Full Text] [Related]
6. [5-FU, FT-207 and uracil concentrations in the serum and tissues of patients with cervical cancer after UFT oral administration].
Tanimura T; Kaneshige E; Fujiwara K; Kobashi Y; Inoue K; Kono I; Sekiba K
Gan To Kagaku Ryoho; 1986 Feb; 13(2):349-55. PubMed ID: 3080967
[TBL] [Abstract][Full Text] [Related]
7. [The serum and tissue concentrations of tegafur, 5-fluorouracil and uracil in patients with gastric and colorectal cancers after oral administration of UFT].
Takahashi N; Nitta A; Saitou T; Mori Y; Kunii Y; Kikuchi K
Gan To Kagaku Ryoho; 1988 Aug; 15(8):2319-23. PubMed ID: 3136701
[TBL] [Abstract][Full Text] [Related]
8. [5-FU concentration in the blood and tissue of patients with gastric and colorectal cancer after administration of UFT or tegafur].
Arima S; Futami K; Shigeta M; Kinashi M; Shimura H
Gan To Kagaku Ryoho; 1986 Aug; 13(8):2618-24. PubMed ID: 3090940
[TBL] [Abstract][Full Text] [Related]
9. [5-FU concentration in tissues of gastric cancer patients with preoperative administration of UFT--especially in comparison with FT-207].
Takeshita M; Ishikawa H; Seki M; Ikeya T; Miyamoto Y; Izuo M; Tozuka S; Usui R; Kaneko H
Gan No Rinsho; 1985 Oct; 31(13):1697-703. PubMed ID: 3935831
[TBL] [Abstract][Full Text] [Related]
10. [UFT concentration in various tissues from cancer patients].
Kasai Y; Nakanishi Y; Nishi H; Nishindai H; Yoshimoto M; Nakamura T; Hashimoto I; Sawada Y; Mikami J; Bekki E
Gan To Kagaku Ryoho; 1983 Oct; 10(10):2130-8. PubMed ID: 6414381
[TBL] [Abstract][Full Text] [Related]
11. [The concentration in the tissue and antitumor effect of anticancer drug--assessment of breast cancer with UFT or FT-207].
Kimura M; Koida T; Sugihara S
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2389-92. PubMed ID: 3089177
[TBL] [Abstract][Full Text] [Related]
12. [Tissue UFT distribution and histological changes following UFT administration in metastatic liver cancer cases].
Yoshikawa K; Iwasaki T; Amemiya A; Emoto T; Fujii M; Han N; Itou A; Tsujimura T
Gan To Kagaku Ryoho; 1990 Jul; 17(7):1333-7. PubMed ID: 2114828
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacodynamic study on the effectiveness of UFT against cancer of gastro-intestinal (GI) tract].
Seo Y; Matsuoka H; Kakeji Y; Morita M; Ohno S; Matsukuma A; Tomoda H; Furusawa M
Gan To Kagaku Ryoho; 1993 Sep; 20(12):1775-80. PubMed ID: 8379669
[TBL] [Abstract][Full Text] [Related]
14. [Drug concentration in cancerous large bowel tissue and thymidylate synthase inhibition rate after administration of tegafur and UFT].
Futami K; Arima S; Yoshimura S; Okamoto T; Yamasaki K; Koto T; Yamasaki S; Kawahara K; Ikuno T
Gan To Kagaku Ryoho; 1991 Feb; 18(2):215-20. PubMed ID: 1992915
[TBL] [Abstract][Full Text] [Related]
15. [Determination of 5-FU tissue concentrations after oral UFT administration in tumors of the head and neck].
Somekawa Y; Asano K; Taira A; Imai R
Gan To Kagaku Ryoho; 1996 Jan; 23(1):75-9. PubMed ID: 8546473
[TBL] [Abstract][Full Text] [Related]
16. [5-FU concentration in the serum and the tumor tissue after administration of UFT 200 mg/day to patients over 80 years of age with oral cancer].
Iida A; Takagi R; Hoshina H; Ono K; Kaji M; Tsurumaki H; Fukuda J; Nagashima K; Miyaura Y; Hayatsu M; Miyamoto T
Gan To Kagaku Ryoho; 2000 Sep; 27(10):1527-32. PubMed ID: 11015997
[TBL] [Abstract][Full Text] [Related]
17. [Level of 5-FU in cancerous and normal tissues of nude mice after oral administration of tegafur coadministered with uracil (UFT)].
Sekiguchi I; Suzuki M; Tamada T; Nishida M
Gan To Kagaku Ryoho; 1985 May; 12(5):1094-8. PubMed ID: 3922312
[TBL] [Abstract][Full Text] [Related]
18. [Level of 5-FU in uterine cervical cancer tissue after oral administration of UFT].
Suzuki M; Sekiguchi I; Ohwada M; Tamada T
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2139-44. PubMed ID: 3933435
[TBL] [Abstract][Full Text] [Related]
19. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231
[TBL] [Abstract][Full Text] [Related]
20. [5-FU concentration in tumor tissue and the antitumor effect in patients with gastric cancer after oral administration of UFT].
Fukunaga H; Katsumi M; Aoki Y; Oka S; Konishi R; Yukawa H; Kawaguchi T; Tamaki Y; Takifuji K
Gan To Kagaku Ryoho; 1987 Sep; 14(9):2735-9. PubMed ID: 3115184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
